VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 230 filers reported holding VERACYTE INC in Q2 2023. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,190 | -99.7% | 98,214 | +99.5% | 0.22% | +100.9% |
| Q3 2022 | $817,000 | +171.4% | 49,228 | +351.1% | 0.11% | +170.0% |
| Q1 2022 | $301,000 | -1.0% | 10,913 | -12.6% | 0.04% | -47.4% |
| Q1 2020 | $304,000 | +9.0% | 12,491 | +7.5% | 0.08% | +100.0% |
| Q3 2019 | $279,000 | -83.1% | 11,624 | -79.9% | 0.04% | -79.5% |
| Q2 2019 | $1,651,000 | +62.7% | 57,895 | +42.8% | 0.18% | +79.6% |
| Q1 2019 | $1,015,000 | +12.7% | 40,551 | -43.4% | 0.10% | -1.0% |
| Q4 2018 | $901,000 | +194.4% | 71,600 | +123.8% | 0.10% | +511.8% |
| Q3 2018 | $306,000 | +78.9% | 32,000 | +74.9% | 0.02% | +112.5% |
| Q2 2018 | $171,000 | -24.3% | 18,300 | -29.1% | 0.01% | -46.7% |
| Q3 2017 | $226,000 | -9.6% | 25,800 | -14.0% | 0.02% | -6.2% |
| Q2 2017 | $250,000 | +41.2% | 30,000 | +55.4% | 0.02% | +77.8% |
| Q1 2017 | $177,000 | +51.3% | 19,300 | +27.8% | 0.01% | +28.6% |
| Q4 2016 | $117,000 | – | 15,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |